$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Gilead Sciences : to Expand Manufacturing Of Covid-19 Drug Remdesivir | MarketScreener
09:35pm, Thursday, 30'th Apr 2020About half of U.S. states easing coronavirus restrictions as jobless numbers grow
08:25pm, Thursday, 30'th Apr 2020
With initial White House social-distancing guidelines expiring on Thursday, about half the U.S. states were pressing ahead with plans to ease restrictions on businesses and social life, aiming to revi
U.S. states grapple with reopening as virus forces millions more jobless claims
03:14pm, Thursday, 30'th Apr 2020
More than two dozen U.S. states moved ahead with plans to relax restrictions on business and social life, hoping to reverse the economic blows of the coronavirus that led to another 3.89 million Ameri
Gilead Is Still Waiting for FDA Approval to Use Remdesivir to Treat Covid-19
01:16pm, Thursday, 30'th Apr 2020
Twenty-four hours after Gilead Sciences announced positive results from a government study of its experimental Covid-19 drug remdesivir, the FDA has made no public move to authorize the drug for emerg
Musk vs. Zuck: A tale of two CEOs acting much differently during a pandemic
10:55am, Thursday, 30'th Apr 2020
The stark contrast in how Elon Musk and Mark Zuckerberg are dealing with the global pandemic was on display Wednesday, with Tesla’s CEO calling the ongoing...
Until we have a vaccine for coronavirus, treatments like remdesivir are our only hope | Jennifer Rohn
08:00am, Thursday, 30'th Apr 2020
Conflicting evidence from early trials is the norm in science. We must be patient as the data unfolds, says UCL biologist Dr Jennifer Rohn
Report: NBA eyes Disney World, encouraged by new medicines
01:47am, Thursday, 30'th Apr 2020
The NBA is looking at the Walt Disney World Resort near Orlando, Fla., as a possible playing site should the 2019-20 season resume, and has even gotten the OK from Disney to use the site, Stadium's Sh
Drug Hopes Overshadow GDP
12:00am, Thursday, 30'th Apr 2020
Market Overview Analysis by Market Crumbs covering: Gilead Sciences Inc. Read Market Crumbs 's latest article on Investing.com
Jim Cramer on Wednesday's rally: 'Remdesivir is just what the doctor ordered'
11:03pm, Wednesday, 29'th Apr 2020
"This drug makes a big difference, especially if you were worried about a second wave of infections after we reopened the economy," the "Mad Money" host said.
Coronavirus latest: at a glance
10:35pm, Wednesday, 29'th Apr 2020
A summary of the biggest developments in the global coronavirus outbreak
US stock futures rise after solid tech earnings, Facebook up 10%
10:06pm, Wednesday, 29'th Apr 2020
Futures contracts tied to the major U.S. stock indexes rose Wednesday evening after upbeat revenue results from both Facebook and Microsoft.
Here's what happened to the stock market on Wednesday
08:08pm, Wednesday, 29'th Apr 2020
Wednesday's rally on Wall Street was sparked by positive data from a potential coronavirus treatment from Gilead Sciences.
Gilead says shorter remdesivir regimen is effective and drug met main goal in government study
12:57pm, Wednesday, 29'th Apr 2020
Gilead Sciences Inc. undefined on Wednesday morning announced data from two clinical trials testing its experimental drug remdesivir in severely ill COVID-19...
Gilead reports 'positive data' on remdesivir coronavirus drug trial
12:36pm, Wednesday, 29'th Apr 2020ADMA Biologics to Report First Quarter 2020 Financial Results on May 6, 2020
11:00am, Wednesday, 29'th Apr 2020
ADMA’s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates. A live audio webcast of the call w
Sign In
Buy ADMA